Gsa Capital Partners LLP Organogenesis Holdings Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 79,024 shares of ORGO stock, worth $357,978. This represents 0.02% of its overall portfolio holdings.
Number of Shares
79,024Holding current value
$357,978% of portfolio
0.02%Shares
15 transactions
Others Institutions Holding ORGO
# of Institutions
137Shares Held
68.8MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.5 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M3.28MShares$14.8 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...